IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
This study has been completed.
Sponsor:
Altor Bioscience Corporation
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Altor Bioscience Corporation
ClinicalTrials.gov Identifier:
NCT01029873
First received: December 9, 2009
Last updated: October 26, 2016
Last verified: October 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2013 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | July 23, 2013 |